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Abstract. 
EDEN (Embryo Deadenylation ElemeNt) dependent deadenylation is a regulatory process 
that was initially identified in Xenopus laevis early embryos and was subsequently shown to 
exist in Drosophila oocytes. Recent data showed that this regulatory process is required for 
somitic segmentation in Xenopus. Inactivation of EDEN- binding protein (EDEN-BP) causes 
severe segmentation defects and the expression of segmentation markers in the Notch 
signalling pathway are disrupted. We showed that the mRNA encoding Xenopus Suppressor 
of Hairless, a protein central to the Notch pathway, is regulated by EDEN-BP. Our data also 
indicate that other segmentation RNAs are targets for EDEN-BP. To identify new EDEN-BP 
targets a micro-array analysis has been undertaken. 
 
Introduction 
The post-transcriptional regulation of gene expression within the cytoplasm of cells 
has numerous facets such as translational activation or silencing and localisation. Control of 
gene expression at this level is particularly important in oocytes and early embryos. Indeed, in 
all species studied to date transcription is essentially silent during the completion of meiosis 
(maturation) and the first mitotic divisions. This situation has both high-lighted the 
importance of post-transcriptional controls and enabled the study of these mechanisms. In 
Xenopus, mouse and probably many other species one of the major mechanisms that activates 
or represses the translation of maternally inherited mRNAs is via a control of the poly(A) tail 
length. Two sequence elements required for post-fertilisation deadenylation (poly(A) tail 
shortening) have been identified; the Embryo Deadenylation ElemeNt (EDEN) [1] and the 
AUUUA containing AU rich elements [2] both localised within the 3' untranslated region 
(3'UTR) of affected mRNAs. It is necessary to mention that contrary to the general situation 
in somatic cells, in early embryos deadenylated mRNAs are not immediately degraded and 
the coupling between mRNA deadenylation and degradation is only restored after the 
resumption of transcriptional activity at the 12 th mitotic cell cycle [2-4]. This may have 
developmental importance as the "protection" of deadenylated mRNAs implies that 
maternally inherited poly(A)- mRNAs whose translation is activated after the initial mitotic 
cycles are also protected. We will concentrate here on the EDEN-dependent pathway. 
 
The EDEN sequence. 
Mapping for regulatory sequences in the 3'UTR of mRNAs deadenylated in embryos 
has shown that functional EDENs are situated within U/purine rich regions (reviewed in [5]). 
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Indeed, a synthetic motif composed of at least 6 contiguous (UGUA) motifs can confer post-
fertilization deadenylation on a reporter mRNA [6]. However, comparison of the EDEN-
containing regions has not identified any particularity sequence motif, so, to date, EDENs can 
not be efficiently identified using in silico based methods. To complicate the picture, two 
auxiliary sequence elements that assist the EDEN mechanism have been identified, an AUU 
repetition [6] and a single AUUUA motif [7]. 
In oocytes and early embryos deadenylation is strongly correlated with translational 
repression. This functional aspect of the EDEN is evolutionary conserved as the translation of 
a reporter mRNA containing a synthetic EDEN is repressed in the ovaries of transgenic 
Drosophila [8] whereas the stability and localisation of the mRNA were normal. This 
regulatory mechanism is also probably conserved in humans as the instability element in the 
3'UTR of human c-jun mRNA is U/purine rich and behaves like an EDEN when present 
within the 3'UTR of a reporter mRNA injected into Xenopus embryos [9]. 
 
EDEN-BP, the associated factor. 
Most regulatory RNA motifs function as target sites for sequence specific RNA-
binding proteins that are, directly or indirectly, the functional actors in the regulatory 
processes. The protein binding to the EDEN, EDEN-binding protein (EDEN-BP) is a 54 kDa 
protein containing 3 RNA recognition motifs, two in the N-terminal region and one in the C-
terminal part [1]. It is required for the EDEN-dependent deadenylation process. The particular 
arrangement of the three RNA recognition motifs is characteristic of a large super-family of 
proteins including the drosophila Elav and bruno proteins and the mammalian Hu proteins. At 
the amino acid level EDEN-BP has 88% identity with the human protein CUG-binding 
protein 1 and this protein can functionally replace EDEN-BP in a Xenopus extract [10]. 
 
Biological Roles. 
With the intention of identifying a biological role for EDEN-dependent deadenylation 
we developed a protocol to inactivate EDEN-BP in Xenopus embryos using either antisense 
morpholinos oligonucleotides or neutralizing antibodies [11]. The most important phenotype 
observed was a disruption of somitic segmentation (see Figure). Somites are prospective 
muscle and bones. They are made of a series of similar and successive units by a process 
termed segmentation. In EDEN-BP inhibited embryos, loss of segmentation is associated with 
a modified expression of a number of markers in the presomitic mesoderm (PSM), where 
segmentation takes place and which comprises the tail bud domain and presumptive somites 
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(see Figure). Using a candidate gene approach we found one mRNA that is post-
transcriptionally regulated by EDEN-BP in the PSM. This mRNA encodes XSu(H) (Xenopus 
Suppressor of Hairless) a protein central in the Notch signalling pathway. EDEN-BP knock-
down reduced the efficiency of deadenylation targeted by the 3'UTR of XSu(H) and caused an 
over-expression of XSu(H) mRNA. Also over-expressing XSu(H) caused segmentation 
defects. XSu(H) is required for the transcriptional activation of Notch target genes and our 
data indicates that its over-expression disrupts the correct regulation of these genes. 
 
New EDEN-BP targets. 
If XSu(H) was the only mRNA targeted by EDEN-BP in the PSM then a morpholino 
induced down regulation of this gene product should rescue the phenotype caused by EDEN-
BP inactivation. This was not observed which implies that other mRNAs expressed in the 
PSM are also targets for this regulatory pathway [11]. As a first step in the identification of 
such mRNAs a DNA micro-array screen was initiated to analyse specific changes in the 
adenylation status of Xenopus tropicalis maternal mRNAs. Of the 3000 gene products tested 
about 500 showed detectable adenylation changes and could be classified into 7 characteristic 
behaviours (A. Graindorge, Y. Audic, R Thuret, N. Pollet, H.B.Osborne unpublished data). 
 
Perspectives. 
Future work on the molecular characterisation of the EDEN-dependent deadenylation 
mechanism will involve the identification of interacting proteins and a characterisation of 
their functional roles coupled with a wide scale identification of the mRNA targets and a 
description of their expression patterns in the embryos and adult tissues.  
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Legend to figure: 
 
Figure  In vivo inhibition of EDEN-BP causes segmentation defects. 
Left panel: Inhibiting the translation of EDEN-BP mRNA by oligonucleotide morpholinos 
(Mo) causes an accumulation of XSu(H) mRNA. The co-injection of a mRNA encoding 
EDEN-BP (modified to escape down-regulation by the Mo) prevents XSu(H) over-
expression. NI not-injected. Middle panel: XSu(H) is a central element in Notch signalling 
and the mRNAs encoding many proteins implicated in this pathway are expressed in a 
stripped pattern (panels A and C). Inhibiting EDEN-BP expression by Mo causes important 
modifications in the expression patterns of at least two of the mRNAs encoding Notch 
signalling proteins, ESR 5 and X Delta 2 (panels B and D). TBD, tail bud domain, S1 to S4 
correspond to four presumptive somites. Right panel: Inhibiting EDEN-BP causes 
segmentation defects. The bottom half of the embryos is derived from one cell of a 2 cell 
embryo injected with anti EDEN-BP antibodies. The upper half, derived from the non-
injected cell, serves as a control. (n) notochord; (s) somite, Scale bar 50µm. (Modified from 
Gautier et al., 2004, Reproduced with permission from the Company of Biologist). 
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